Natesto — Carefirst Caremark
15 indications indexed for this drug.
- Breast Cancer Hormone Responsive TumorView coverage criteria
- Delayed PubertyView coverage criteria
- Delayed Puberty In Carefully Selected MalesView coverage criteria
- Delayed Puberty In Males For Select Testosterone InjectionsView coverage criteria
- Gender DysphoriaView coverage criteria
- Gender Dysphoria Transgender And Gender Diverse PersonsView coverage criteria
- Hypogonadotropic HypogonadismView coverage criteria
- Hypogonadotropic Hypogonadism Congenital Or AcquiredView coverage criteria
- Inoperable Metastatic Breast CancerView coverage criteria
- Metastatic Mammary Cancer In FemalesView coverage criteria
- Metastatic Mammary Cancer In Postmenopausal Or OophorectomizView coverage criteria
- Metastatic Mammary Cancer In Women One To Five Years PostmenView coverage criteria
- Metastatic Mammary Cancer In Women With Advancing InoperableView coverage criteria
- Primary HypogonadismView coverage criteria
- Primary Hypogonadism Congenital Or AcquiredView coverage criteria